Live Breaking News & Updates on Melanoma Therapeutics

Stay updated with breaking news from Melanoma therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FDA Approves Amtagvi for Pretreated, Advanced Melanoma

The Food and Drug Administration approve Amtagvi, a TIL therapy, for patients with advanced melanoma who had disease progression on or after a checkpoint inhibitor and targeted therapy. ....

Omid Hamid , Research Institute , Sinai Medical Center , Drug Administration , Translational Research , Melanoma Program , Oncology Program , Cedars Sinai Medical Center , Melanoma Therapeutics , Phasei Immuno Oncology Program , Angeles Clinic , Boxed Warning , Skin Cancer ,